EX-99.1
3
exhibit991igambitcyber_carea.htm
PRESS RELEASE
Converted by EDGARwiz
IGAMBIT Announces Acquisition of
CyberCare Health Network, Inc.
Press Release: iGambit Inc. - Thursday, April 6, 2017 2:30PM
EST
SMITHTOWN,
NY,
April
7,
2017
Marketwired
--
iGambit
Inc. (OTCQB: IGMB),
announced that on April 6, 2017 it
acquired the
CyberCare Health Network Division from
EncounterCare Solutions Inc. (ECSL
). Under the terms of the
agreement
iGambit,
bought
certain
assets
of
EncounterCare
.
Payment was made in the form of
IGMB
stock.
CyberCare
will
operate
as
a
division
of
the
recently
acquired
HubCentrix
Company, whose new name is
HealthDatix, Inc
.
A
copy
of
the
Form
8-K
report
may
be
accessed
at
www.sec.gov
.
The acquisition of HubCentrix and the CyberCare Health
Network
Chronic
Care
Management
System provides
a
new
and
unique opportunity for physicians to identify patients eligible for
both "Annual
Wellness Visits" as well as "Chronic Care
Management" both of which are reimbursed by Medicare.
The
goal
of
HealthDatix
will
be
to
identify
the
patient's
eligibility
for
Medicare
reimbursed
doctor
visits
to
access
and
assist in the well-being and cultivation of a healthy lifestyle.
Additionally
HealthDatix
is
able
to
provide
an
FDA
approved,
Medicare
covered
platform,
for
continuous
management
of
chronic
care
patients.
Our
continuous
care
platform
will
be
tailored
for
individual
care
and
health
management
of
patients
susceptible to chronic illness.
The HealthDatix platform is designed to accumulate
information from any TeleMedicine or wearable device.
This
includes
CyberCare's
own
wearable
medical
watch,
a
wearable
device
under
development,
that
will
continuously
collect and trend data.
Key Health Parameters:
. Heart Rate
. Blood Pressure
. Rest/Wake/Activity
. SPO2 (Oxygenation of blood)
. Key Cardiac Function ("Mini-ECG")
Different than other devices on the market:
. Patented Instrumentation
. Medically accurate
. Designed to provide data directly to a health care provider
through HealthDatix solution,
. Share real-time information with health care providers and
family
. Provides better, and earlier, identification of patient health
issues and treatment compliance
The completed wearable, when paired with the CyberCare
Health Network Chronic Care Management System, will
become part of the FDA approved chronic care management
system.
John
Salerno,
Chairman
of
iGambit,:
"As
I
previously
stated
we are very pleased to have this new business opportunity which
we believe will increase our stockholders value. Our
management team and advisors are very accomplished at
introducing and administering rapid growth technology services.
We
anticipate
that
our
exciting
newly
combined
entity
HealthDatix,
will
have
the
professionals
in
place
to
competently
deal
with
the
accelerated
growth
curve
necessary
to
meet
the
needs of physician community throughout the country.
Ronald
Mills
Sr.,
CEO
of
EncounterCare
stated;
I
am
very
pleased that we have been able to successfully complete this
deal with
HealthDatix
and
iGambit.
The
HealthDatix
management team led by Jerry Robinson, President, has put
together
a
very
exciting
program
that
I
believe
will
benefit
the
medical community and which, I also believe will bring
significant value to EncounterCare and our stockholders.
About iGambit
Inc:
iGambit (OTCBB:
IGMB)
is
a
fully
reporting publicly-held company. We are a company focused on
pursuing
specific
medical
strategies
and
objectives. These
objectives
have
included,
among
others,
the
acquisition
of
medical
technology
companies
with
strong
growth
potential
easily
recognized
in
the
public
arena.
We
believe
that
the
back-
ground
of
our
management
and
of
our
Board
of
Directors
in
the
technology
markets
is
a
valuable
resource
that
makes
us
a
desirable
business
partner.
We
expect
to
work
to
assume
an
active
role
in
the
development
and
growth
of
the
new
company,
providing
both
strategic
guidance
and
operational
support.
The
management of iGambit believes that it can leverage its
collective
expertise
to
help
position
the
combined
company
to
produce
high-margin,
recurring
and
predictable
earnings
and
generate long-term value for our stockholders. For more
information,
please
visit
www.igambit.com
.
Information
on
our
web-site does not comprise a part of this press release.
Cautionary Note Regarding Forward-Looking Statements
Certain
statements
in
this
document
and
elsewhere
by
iGambit
are
"forward-looking
statements"
within
the
meaning
of
the
Private
Securities
Litigation
Reform
Act
of
1995.
Such
information
includes,
without
limitation,
the
business outlook,
assessment
of
market
conditions, anticipated
financial
and
operating
results,
strategies,
future
plans,
contingencies
and
contemplated transactions of the company. Such forward-
looking statements are not guarantees of future performance
and
are
subject
to
known
and
unknown
risks,
uncertainties
and
other
factors
which
may
cause
or
contribute
to
actual
results
of
company
operations,
or
the
performance
or
achievements
of
the
company
or
industry
results,
to
differ
materially
from those
expressed,
or
implied
by
the
forward-looking
statements.
In
addition
to
any
such
risks,
uncertainties
and
other
factors
discussed elsewhere herein, risks, uncertainties and other
factors
that
could
cause
or
contribute
to
actual
results
differing
materially from those expressed or implied for the forward-
looking
statements
include,
but
are
not
limited
to
fluctuations
in
demand;
changes
to
economic
growth
in
the
U.S.
and
U.S.
government
policies
and
regulations,
including,
but
not
limited
to
those
affecting
the
medical
fertility
clinic
industry.
iGambit
undertakes no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events
or otherwise. Actual results, performance or achievements could
differ
materially
from
those
anticipated
in
such
forward-looking
statements as a result of certain factors, including those set forth
in
iGambit
Inc.'s
filings
with
the
Securities
and
Exchange
Commission.
Investor Relations Contacts:
Bill Robertson …Ph. No. 604 837 3835

EX - 99 . 1 3 exhibit991igambitcyber _ carea . htm PRESS RELEASE Converted by EDGARwiz IGAMBIT Announces Acquisition of CyberCare Health Network , Inc . Press Release : iGambit Inc . - Thursday , April 6 , 2017 2 : 30 PM EST SMITHTOWN , NY , April 7 , 2017 Marketwired -- iGambit Inc . ( OTCQB : IGMB ) , announced that on April 6 , 2017 it acquired the CyberCare Health Network Division from EncounterCare Solutions Inc . ( ECSL ) . Under the terms of the agreement iGambit , bought certain assets of EncounterCare . Payment was made in the form of IGMB stock . CyberCare will operate as a division of the recently acquired HubCentrix Company , whose new name is HealthDatix , Inc . A copy of the Form 8 - K report may be accessed at www.sec.gov . The acquisition of HubCentrix and the CyberCare Health Network Chronic Care Management System provides a new and unique opportunity for physicians to identify patients eligible for both " Annual Wellness Visits " as well as " Chronic Care Management " both of which are reimbursed by Medicare . The goal of HealthDatix will be to identify the patient 's eligibility for Medicare reimbursed doctor visits to access and assist in the well - being and cultivation of a healthy lifestyle . Additionally HealthDatix is able to provide an FDA approved , Medicare covered platform , for continuous management of chronic care patients . Our continuous care platform will be tailored for individual care and health management of patients susceptible to chronic illness . The HealthDatix platform is designed to accumulate information from any TeleMedicine or wearable device . This includes CyberCare 's own wearable medical watch , a wearable device under development , that will continuously collect and trend data . Key Health Parameters : . Heart Rate . Blood Pressure . Rest / Wake / Activity . SPO2 ( Oxygenation of blood ) . Key Cardiac Function ( " Mini - ECG " ) Different than other devices on the market : . Patented Instrumentation . Medically accurate . Designed to provide data directly to a health care provider through HealthDatix solution , . Share real - time information with health care providers and family . Provides better , and earlier , identification of patient health issues and treatment compliance The completed wearable , when paired with the CyberCare Health Network Chronic Care Management System , will become part of the FDA approved chronic care management system . John Salerno , Chairman of iGambit , : " As I previously stated we are very pleased to have this new business opportunity which we believe will increase our stockholders value . Our management team and advisors are very accomplished at introducing and administering rapid growth technology services . We anticipate that our exciting newly combined entity HealthDatix , will have the professionals in place to competently deal with the accelerated growth curve necessary to meet the needs of physician community throughout the country . Ronald Mills Sr . , CEO of EncounterCare stated ; I am very pleased that we have been able to successfully complete this deal with HealthDatix and iGambit . The HealthDatix management team led by Jerry Robinson , President , has put together a very exciting program that I believe will benefit the medical community and which , I also believe will bring significant value to EncounterCare and our stockholders . About iGambit Inc : iGambit ( OTCBB : IGMB ) is a fully reporting publicly - held company . We are a company focused on pursuing specific medical strategies and objectives . These objectives have included , among others , the acquisition of medical technology companies with strong growth potential easily recognized in the public arena . We believe that the back - ground of our management and of our Board of Directors in the technology markets is a valuable resource that makes us a desirable business partner . We expect to work to assume an active role in the development and growth of the new company , providing both strategic guidance and operational support . The management of iGambit believes that it can leverage its collective expertise to help position the combined company to produce high - margin , recurring and predictable earnings and generate long - term value for our stockholders . For more information , please visit www.igambit.com . Information on our web - site does not comprise a part of this press release . Cautionary Note Regarding Forward - Looking Statements Certain statements in this document and elsewhere by iGambit are " forward - looking statements " within the meaning of the Private Securities Litigation Reform Act of 1995 . Such information includes , without limitation , the business outlook , assessment of market conditions , anticipated financial and operating results , strategies , future plans , contingencies and contemplated transactions of the company . Such forward - looking statements are not guarantees of future performance and are subject to known and unknown risks , uncertainties and other factors which may cause or contribute to actual results of company operations , or the performance or achievements of the company or industry results , to differ materially from those expressed , or implied by the forward - looking statements . In addition to any such risks , uncertainties and other factors discussed elsewhere herein , risks , uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward - looking statements include , but are not limited to fluctuations in demand ; changes to economic growth in the U . S . and U . S . government policies and regulations , including , but not limited to those affecting the medical fertility clinic industry . iGambit undertakes no obligation to publicly update any forward - looking statements , whether as a result of new information , future events or otherwise . Actual results , performance or achievements could differ materially from those anticipated in such forward - looking statements as a result of certain factors , including those set forth in iGambit Inc . 's filings with the Securities and Exchange Commission . Investor Relations Contacts : Bill Robertson … Ph . No . 604 837 3835
O O O O O O O O O O O O O O O O B-Parties.BUYING_COMPANY O O O B-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY O O O O O O O O O O O O O O O O B-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY O B-Parties.SELLING_COMPANY I-Parties.SELLING_COMPANY I-Parties.SELLING_COMPANY I-Parties.SELLING_COMPANY O O O O O O O O O O B-Parties.BUYING_COMPANY O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Parties.ACQUIRED_COMPANY O O B-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O